drugset / Trial / NCT07285629
Safety and Efficacy of Klotho and Follistatin Gene Therapy
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to investigate the safety and efficacy of a combination klotho and follistatin gene therapy, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of this gene therapy.
Timeline
- Start
- 2025-12-16
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Follistatin | Other / unclassified | — | Subcutaneous |
| Subject | Klotho | Other / unclassified | — | Subcutaneous |
Indications
No indication recorded.